Hologic Inc. Stock Price Declines Following Analyst Downgrade

Hologic Inc., a developer of diagnostic products and medical imaging systems, has experienced a decline in its stock price over recent days. The company’s shares reached a new 52-week low after an analyst downgrade, with the stock trading as low as $52.15 before closing at $52.94 on Friday.

Market Impact

The market value of Hologic Inc. has been impacted by the analyst downgrade. Mizuho reduced its price target for Hologic stock to $65 from $75.

Stock Performance

Hologic’s stock price performance over the past five years has shown a modest gain of approximately 7.72%.

Core Business Units

Despite the decline in stock price, Hologic’s core business units, which focus on diagnostics and medical imaging, continue to drive the company’s growth.

Key Statistics

  • New 52-week low: $52.15
  • Closing price on Friday: $52.94
  • Price target reduction: $65 (from $75)
  • Stock performance over the past five years: 7.72% gain